alexa New Strategies for Improving the Quality of Life of Can
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review

New Strategies for Improving the Quality of Life of Cancer Survivors: Reversible p53 Inhibition

Nesrine Benkafadar1,2, Carolanne Coyat1,2, Ruth Lloyd1,3, Jean-Luc Puel1,2 and Jing Wang1,2*

1INSERM-UMR 1051, Institut des Neurosciences de Montpellier, 34295 Montpellier, France

2Université de Montpellier, 34295 Montpellier, France

3Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, UK

*Corresponding Author:
Jing Wang
INSERM-UMR 1051, Institut des
Neurosciences de Montpellier
34295 Montpellier, France
Tel: 33499 636 048
Fax: 33499 636 020
E-mail: [email protected]

Received Date: May 31, 2017 Accepted Date: June 23, 2017 Published Date: June 26, 2017

Citation: Benkafadar N, Coyat C, Lloyd R, Jean-Luc P, Wang J (2017) New Strategies for Improving the Quality of Life of Cancer Survivors: Reversible p53 Inhibition. J Cancer Sci Ther 9: 490-491. doi: 10.4172/1948-5956.1000464

Copyright: © 2017 Benkafadar N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

In recent years, with the improvement of cancer survival through more effective treatment, the emphasis has been in trying to minimize the side-effects caused by chemo- and radiotherapy, to ensure that patients have the best quality of life throughout their cancer journey. The tumor suppressor p53 is widely implicated in a broad range of cancers, and here we summarize its role and the possibilities of its manipulation to improve side effects during active treatment through survivorship.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords